CCEL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CCEL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cryo-Cell International's Dividends per Share for the three months ended in Aug. 2024 was $0.00.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
Cryo-Cell International's Dividend Payout Ratio for the three months ended in Aug. 2024 was 0.00. As of today, Cryo-Cell International's Dividend Yield % is 3.19%.
For more information regarding to dividend, please check our Dividend Page.
For the Medical Care Facilities subindustry, Cryo-Cell International's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's 5-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Cryo-Cell International's 5-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
Cryo-Cell International (AMEX:CCEL) 5-Year Dividend Growth Rate Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Cryo-Cell International's Dividend Payout Ratio for the quarter that ended in Aug. 2024 is calculated as
Dividend Payout Ratio | = | Dividends per Share (Q: Aug. 2024 ) | / | EPS without NRI (Q: Aug. 2024 ) |
= | 0 | / | 0.082 | |
= | 0.00 |
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Cryo-Cell International Recent Full-Year* Dividend History
Amount | Ex-date | Record Date | Pay Date | Type | Frequency | Forex Rate |
---|---|---|---|---|---|---|
USD 0.250000 | 2024-11-15 | 2024-11-15 | 2024-11-29 | Cash Dividend | quarterly | USD:USD 1.000000 |
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Cryo-Cell International's Dividend Yield (%) for Today is calculated as
Dividend Yield % | = | Most Recent Full Year Dividend | / | Current Share Price |
= | 0.25 | / | 7.835 | |
= | 3.19 % |
Current Share Price is $7.835.
Cryo-Cell International's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.25.
During the past 13 years, the highest Dividend Yield of Cryo-Cell International was 3.22%. The lowest was 0.00%. And the median was 0.00%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Cryo-Cell International's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
David Portnoy | director, officer: Co-Chief Executive Officer | C/O FOCUS FINANCIAL GROUP, 61 HARBOUR WAY, BAL HARBOUR FL 33154 |
George Gaines | director | 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677 |
Jonathan H. Wheeler | director | 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677 |
Brian L. Sheehy | director | 415 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10017 |
Mark L. Portnoy | director, officer: Co-Chief Executive Officer | 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677 |
Harold D. Berger | director | 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677 |
Arthur Ellis | director | 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677 |
Mary J Nyberg | 10 percent owner | 455 E MAYO BLVD, UNIT 5202, PHOENIX AZ 85050 |
Cdmj Nyberg Family Trust | 10 percent owner | 455 E MAYO BLVD, UNIT 5202, PHOENIX AZ 85050 |
Jill M Taymans | officer: VP, Finance, CFO | |
Oleg Mikulinsky | officer: Chief Information Officer | 700 BROOKER CREEK BLVD., SUITE 1800, OLDSMAR FL 34677 |
Anthony Atala | director | 700 BROOKER CREEK BOULEVARD, OLDSMAR FL 34677 |
Scott G Christian | director | |
Sung Won Sohn | director | 700 BROOKER CREEK BLVD., SUITE 1800, OLDSMAR FL 34677 |
Michael W. Cho | director | C/O IOWA STATE UNIVERSITY, 1600 S. 16TH STREET, AMES IA 50011-1250 |
From GuruFocus
By Marketwired Marketwired • 02-26-2021
By GuruFocus Research GuruFocus Editor • 04-20-2021
By GuruFocus Research GuruFocus Editor • 01-20-2021
By GuruFocusNews GuruFocusNews • 04-13-2022
By GuruFocusNews GuruFocusNews • 03-09-2022
By Marketwired Marketwired • 08-30-2021
By [email protected] insider • 07-28-2020
By GF Value GF Value • 04-04-2021
By Marketwired Marketwired • 09-20-2021
By Marketwired Marketwired • 10-27-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.